PROCYON CORPORATION

PCYN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Operating Activities
Net Income $109.6K $-218.3K $23.6K $-104.3K $128.5K $192.9K
Depreciation & Amortization
Depreciation $37.7K $35.9K $32.8K $32.5K $33.4K $35.7K
Amortization
Stock-Based Compensation $5.1K $-527 $-613 $-812 $-577 $262
Net Cash from Operating Activities $18.7K $-392.0K $-179.5K $-13.4K $430.9K $129.1K
Investing Activities
Capital Expenditures $73.3K $66.5K $10.5K $12.5K $7.0K $56.9K
Business Acquisitions
Net Cash from Investing Activities $-207.1K $-66.5K $-10.5K $-12.5K $-7.0K $-158.2K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $43.3K $80.0K $-108.5K $-237.9K $-77.3K
Net Change in Cash $-145.1K
Free Cash Flow $-54.6K $-458.5K $-190.0K $-25.9K $423.9K $72.2K
← Newer Page 2 of 2 Older →